LEBOVITS CHAIM (See Remarks) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/7/2024ACC: 0001104659-24-058218
Officer· See Remarks
Since Jul 2018
+66.30K
Net shares
Net buyer
$24.8K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
66.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+66.30K
Price / share
$0.37
Trade value
$24.82K
% of position
6.7%
5/7/2024
993.57K→1.06M
Total
Net shares
+66.30K
Net value
$24.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/7/2024 | A · Award | +66.30K | $0.37 | $24.82K | 6.7% | 993.57K | 1.06M |
| Total | +66.30K | $24.82K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported